BSD Medical Reports that Increasing Clinical Use of Hyperthermia for Cancer Treatment was the Focus at Society for Thermal Medicine Meeting

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, today reported that the focus at the annual Society of Thermal Medicine (STM) (www.thermaltherapy.org) conference, which was held in New Orleans from April 29 to May 2, 2011, was the increasing clinical use of hyperthermia in the treatment of cancer. The researchers at the meeting presented data showing significant benefits for the use of hyperthermia to treat a variety of tumors, including breast, prostate, head and neck, cervix, soft tissue sarcomas and bladder cancer. A number of presentations also discussed the importance of studying the use of hyperthermia and chemotherapy for the treatment of non-muscle invasive bladder cancer.

MORE ON THIS TOPIC